SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robohogs who wrote (10087)5/21/2007 1:49:04 AM
From: Robohogs   of 10280
 
2009 Estimates by Product



            DB   Baird (08) Sanford  Natex   Stanford   CS
Lunesta    761      771       745     698      822      873
Xop        412      511       494     535      460      495
HFA        465      219       266     240      257      435
Brovana    175      186       241     175      408      110
Royal       33       44        60      36       21       44

Total     1846     1731      1806    1684     1968     1957

EPS (FT)  2.64                                3.50     3.06
EPS       3.41     2.87      3.26    2.68     3.74     4.35  
Target      59       67        48      50       61       47


It is interesting Natexis has lowest estimates because the only
area they are ahead is Xop neb which they have going generic
in 2010 which makes their way out estimates very very low.

Jon
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News